216 related articles for article (PubMed ID: 2553990)
1. Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.
Beck WT
J Natl Cancer Inst; 1989 Nov; 81(22):1683-5. PubMed ID: 2553990
[No Abstract] [Full Text] [Related]
2. Resistance to inhibitors of DNA topoisomerases.
Sullivan DM; Ross WE
Cancer Treat Res; 1991; 57():57-99. PubMed ID: 1686723
[TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase inhibitors.
Capranico G; Giaccone G; Zunino F; Garattini S; D'Incalci M
Cancer Chemother Biol Response Modif; 1994; 15():67-86. PubMed ID: 7779607
[No Abstract] [Full Text] [Related]
4. Yeast as a genetic model system for studying topoisomerase inhibitors.
Nitiss JL
Adv Pharmacol; 1994; 29B():201-26. PubMed ID: 8996609
[No Abstract] [Full Text] [Related]
5. Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.
Tan KB; Mattern MR; Eng WK; McCabe FL; Johnson RK
J Natl Cancer Inst; 1989 Nov; 81(22):1732-5. PubMed ID: 2553992
[TBL] [Abstract][Full Text] [Related]
6. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
Nitiss JL; Nitiss KC
Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
[No Abstract] [Full Text] [Related]
7. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
Furukawa M; Harada T; Tanaka T; Kuwano M
Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
Levac P; Moss T
Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
[TBL] [Abstract][Full Text] [Related]
11. Characterization of camptothecin-resistant Chinese hamster lung cells.
Chang JY; Dethlefsen LA; Barley LR; Zhou BS; Cheng YC
Biochem Pharmacol; 1992 Jun; 43(11):2443-52. PubMed ID: 1319161
[TBL] [Abstract][Full Text] [Related]
12. Identification of topoisomerase I mutations affecting both DNA cleavage and interaction with camptothecin.
Li XG; Haluska P; Hsiang YH; Bharti A; Kufe DW; Rubin EH
Ann N Y Acad Sci; 1996 Dec; 803():111-27. PubMed ID: 8993505
[No Abstract] [Full Text] [Related]
13. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
Pan X; Hartley JM; Hartley JA; White KN; Wang Z; Bligh SW
Phytomedicine; 2012 May; 19(7):618-24. PubMed ID: 22402246
[TBL] [Abstract][Full Text] [Related]
14. [Pleiotropic resistance associated with topoisomerases].
Riou JF; Pommier Y
Bull Cancer; 1994 Dec; 81 Suppl 2():62s-68s. PubMed ID: 7727861
[TBL] [Abstract][Full Text] [Related]
15. Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content.
Woessner RD; Eng WK; Hofmann GA; Rieman DJ; McCabe FL; Hertzberg RP; Mattern MR; Tan KB; Johnson RK
Oncol Res; 1992; 4(11-12):481-8. PubMed ID: 1338578
[TBL] [Abstract][Full Text] [Related]
16. Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis.
Li XG; Haluska P; Hsiang YH; Bharti AK; Kufe DW; Liu LF; Rubin EH
Biochem Pharmacol; 1997 Apr; 53(7):1019-27. PubMed ID: 9174116
[TBL] [Abstract][Full Text] [Related]
17. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance associated with altered DNA topoisomerase II.
Beck WT; Danks MK; Wolverton JS; Kim R; Chen M
Adv Enzyme Regul; 1993; 33():113-27. PubMed ID: 8395133
[No Abstract] [Full Text] [Related]
19. Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
Poot M; Epe B; Hoehn H
Mutat Res; 1992 Nov; 270(2):185-9. PubMed ID: 1383735
[TBL] [Abstract][Full Text] [Related]
20. Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.
Carballo M; Giné R; Santos M; Puigdomènech P
Plant Mol Biol; 1991 Jan; 16(1):59-70. PubMed ID: 1653630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
